Daiichi Sankyo is stepping up its interest in RNA therapies, teaming with Nosis Biosciences to design drug candidates capable ...

Johns Hopkins scientists develop mRNA "booster" as potential new way to treat rare genetic diseases marked by too low levels ...

In the pursuit of understanding the pathogenic expression mechanisms of bacteria and the advancements in biofoundry ...

The Nucleic Acid Isolation and Purification Market is projected to be valued at USD 1,178.6 million in 2025 and is expected to grow at a CAGR of 5.6% from 2025 to 2035, reaching USD 2,038.1 million by ...

The growing demand for nucleic acid amplification testing (NAAT) is primarily fueled by the increasing prevalence of infectious and genetic diseases. Additionally, this demand is reinforced by the ...

Maravai’s companies are leaders in providing products and services in the fields of nucleic acid synthesis and biologics ... gene therapy, and RNA therapeutic development with cutting-edge ...

Diagnostics, Inc. (Nasdaq: CODX) (the "Company" or "Co-Dx"), a molecular diagnostics company with a unique, patented platform ...

Vitamin B12, also known as cobalamin, is a water-soluble vitamin that is essential for developing and maintaining a healthy ...